Skip to main content

Table 1 Baseline characteristics of the study groups

From: Effect of minocycline on the left ventricular function following ST-elevation myocardial infarction treated by primary percutaneous coronary intervention

Characteristic Control (n=39) Intervention (n=34) P value*
Age, year 57.3±9.1 56.5±10.7 0.749
Male gender, n (%) 32 (82.1) 31 (91.2) 0.321
BMI, kg/m2 27.5±4.3 28.1±2.9 0.510
Diabetes mellitus, n (%) 4 (10.3) 6 (17.6) 0.499
Hypertension, n (%) 18 (46.2) 10 (29.4) 0.142
Dyslipidemia, n (%) 14 (35.9) 20 (58.8) 0.050
Smoking, n (%) 15 (38.5) 12 (35.3) 0.780
Family history of CAD, n (%) 5 (12.8) 4 (11.8) 0.999
Cholesterol, mg/dl 176.6±47.0 173.4±37.2 0.750
Triglyceride, mg/dl 125.0 [88.0, 155.0] 120.0 [78.5, 161.0] 0.932
LDL, mg/dl 114.0 [84.0, 133.0] 112.0 [88.0, 132.5] 0.906
HDL, mg/dl 40.0±8.9 39.6±9.5 0.857
Fasting blood sugar, mg/dl 110.0 [98.0, 126.0] 119.5 [99.0, 137.0] 0.210
Creatinine, mg/dl 0.88±0.17 0.90±0.19 0.645
MMP-9, μg/dl 111.0±20.0 106.5±27.4 0.437
  1. BMI body mass index, bpm beats per minute, CAD coronary artery disease, HDL high-density lipoprotein, LDL low-density lipoprotein, MMP matrix metalloproteinase
  2. *P value less than 0.05 was considered as statistically significant